Development of new-generation HU-PBMC-NOD/SCID mice to study human islet alloreactivity.
Document Type
Article
Publication Date
2007
Keywords
Crosses-Genetic, Diabetes-Mellitus-Type-1, Disease-Models-Animal, Humans, Islets-of-Langerhans, Isoantigens, Leukocytes-Mononuclear, Mice-Inbred-BALB-C, Mice-Inbred-NOD, Mice-SCID
First Page
90
Last Page
93
JAX Location
see Reprint Collection or Book Collection W1 AN626YL v.1103 2007
JAX Source
Ann N Y Acad Sci 2007; 1103:90-3.
Abstract
The use of "humanized" mice represents an appealing translational model for studies of the pathogenesis of immune-mediated diseases and for the evaluation of potential therapeutics. The utility of humanized mice depends on their ability to model the human immune system with high fidelity, and, in this respect, previous models have fallen short. The recently developed NOD-scid Il2rgamma(null) mouse, however, exhibits greatly enhanced ability to support the engraftment of human peripheral blood mononuclear cells. Herein, we describe the challenges of recapitulating human immunity in humanized mice and features of NOD-scid Il2rgamma(null) mice that help overcome them.
Recommended Citation
King M,
Pearson T,
Shultz LD,
Leif J,
Bottino R,
Trucco M,
Atkinson M,
Wasserfall C,
Herold K,
Mordes JP,
Rossini AA,
Greiner DL.
Development of new-generation HU-PBMC-NOD/SCID mice to study human islet alloreactivity. Ann N Y Acad Sci 2007; 1103:90-3.